IRIS
Ceribelli, Angela
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.016
EU - Europa 773
AF - Africa 638
AS - Asia 332
SA - Sud America 11
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.773
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.008
SC - Seychelles 610
FI - Finlandia 200
SG - Singapore 149
IT - Italia 145
IE - Irlanda 138
CN - Cina 124
DE - Germania 70
FR - Francia 58
IN - India 35
NL - Olanda 35
GB - Regno Unito 29
NG - Nigeria 26
SE - Svezia 18
MK - Macedonia 17
CZ - Repubblica Ceca 14
BE - Belgio 10
JP - Giappone 7
RU - Federazione Russa 7
TR - Turchia 7
BR - Brasile 6
PH - Filippine 6
PL - Polonia 5
CH - Svizzera 4
AR - Argentina 3
CA - Canada 3
MX - Messico 3
AT - Austria 2
DK - Danimarca 2
EE - Estonia 2
ES - Italia 2
HU - Ungheria 2
IL - Israele 2
NO - Norvegia 2
RO - Romania 2
UA - Ucraina 2
AL - Albania 1
AU - Australia 1
BG - Bulgaria 1
BS - Bahamas 1
CL - Cile 1
DZ - Algeria 1
EU - Europa 1
HR - Croazia 1
IQ - Iraq 1
LI - Liechtenstein 1
NZ - Nuova Zelanda 1
PA - Panama 1
PT - Portogallo 1
RS - Serbia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
UG - Uganda 1
VE - Venezuela 1
Totale 3.773
Salva come PNG Salva come JPEG
Città #
Chandler 598
Helsinki 200
Boardman 161
Dublin 138
Wilmington 124
Ashburn 118
New York 118
Shanghai 104
Singapore 85
Paris 56
San Mateo 52
Los Angeles 39
Ann Arbor 34
Amsterdam 33
Milan 31
Pune 27
Benin City 25
Lawrence 25
Princeton 25
Leawood 22
London 20
Phoenix 16
Woodbridge 16
Fairfield 13
Seattle 12
Brno 11
Brussels 10
Santa Clara 10
Falkenstein 9
Skopje 9
Munich 8
Sassari 8
Aurora 6
Hyderabad 6
Naples 6
Rome 6
San Diego 6
Bitola 5
Frankfurt am Main 5
Kocaeli 5
Abbiategrasso 4
Stockholm 4
Trieste 4
Turin 4
Usmate Velate 4
Buenos Aires 3
Falls Church 3
Moscow 3
Olongapo City 3
Prilep 3
Redwood City 3
Tokyo 3
Toronto 3
Warsaw 3
Acerra 2
Arzano 2
Bari 2
Bologna 2
Budapest 2
Catania 2
Chennai 2
Chieve 2
Gdansk 2
Hanover 2
Lakewood 2
Las Pinas 2
League City 2
Mexico City 2
Monmouth Junction 2
Nagasaki 2
Norwalk 2
Oslo 2
Otemachi 2
Prague 2
Reggio Emilia 2
Sale Marasino 2
Shenzhen 2
Shijiazhuang 2
Tallinn 2
Udine 2
Venegono Superiore 2
Verona 2
Wrentham 2
Zurich 2
Acton 1
Alba 1
Andover 1
Baghdad 1
Belo Horizonte 1
Bollebygd 1
Bratislava 1
Bucharest 1
Cagayan de Oro 1
Canberra 1
Copenhagen 1
Curitiba 1
Dnipro 1
Florence 1
Gaithersburg 1
Gallarate 1
Totale 2.325
Salva come PNG Salva come JPEG
Nome #
Serum anti-phospholipid antibody prevalence and cardiovascular significance in the general population of the camelia study 641
Outcome of Sars-COV-2-related thyrotoxicosis in survivors of Covid-19: a prospective study 136
Personalized medicine in rheumatology : the paradigm of serum autoantibodies 69
UTILIZZO DELLA MEPACRINA COME TERAPIA DELLE MANIFESTAZIONI CUTANEE NELLE CONNETTIVITI 68
Acute phase reactions after zoledronic acid infusion: protective role of 25-OH vitamin D and previous oral bisphosphonate therapy 66
Anti-phospholipid antibody prevalence and association with subclinical atherosclerosis and atherothrombosis in the general population 60
Safety issues and concerns of new immunomodulators in rheumatology 58
Serum antinuclear and extractable nuclear antigen antibody prevalence and associated morbidity and mortality in the general population over 15 years 55
Gamma-delta T lymphocytes and 25-hydroxy vitamin D levels as key factors in autoimmunity and inflammation : the case of zoledronic acid-induced acute phase reaction 52
Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis 51
The Immune Response and the Pathogenesis of Idiopathic Inflammatory Myositis : a Critical Review 48
Suspected and unsuspected factors in the multifaceted immunopathology of viral hepatitis 48
Prevalence and clinical significance of anti-MDA5 antibodies in European patients with polymyositis/dermatomyositis 47
Lessons learned from twins in autoimmune and chronic inflammatory diseases 46
PFAPA syndrome and Behçet’s disease : a comparison of two medical entities based on the clinical interviews performed by three different specialists 45
Anti-RNA polymerase III antibodies: a marker of systemic sclerosis with rapid onset and skin thickening progression 44
Nailfold videocapillaroscopy and serum VEGF levels in scleroderma are associated with internal organ involvement 44
Effects of type II collagen epitope carbamylation and citrullination in HLA-DR4+ monozygotic twins discordant for rheumatoid arthritis 40
Disease knowledge index and perspectives on reproductive issues: A nationwide study on 398 women with autoimmune rheumatic diseases 40
Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course. 39
Anti-TNF-alpha treatment in rheumatoid arthritis with anti-Ro/SSA antibodies. Analysis of 17 cases among a cohort of 322 treated patients 38
Comment on: Inflammatory myopathy associated with anti-mitochondrial antibodies: A distinct phenotype with cardiac involvement 37
A case of psoriatic arthritis triggered by SARS-CoV-2 infection 37
A Comprehensive Overview on Myositis-Specific Antibodies: New and Old Biomarkers in Idiopathic Inflammatory Myopathy 36
DNA Methylation Signature in Monozygotic Twins Discordant for Psoriatic Disease 35
Seronegative reactive spondyloarthritis and the skin 35
Detection of anti-mitochondrial antibodies by immunoprecipitation in patients with systemic sclerosis 35
Humoral Response Against LL-37 in Psoriatic Disease: Comment on the Article by Yuan et al 34
Anti-MDA5 Antibody Linking COVID-19, Type I Interferon, and Autoimmunity: A Case Report and Systematic Literature Review 34
MicroRNAs in rheumatoid arthritis 34
Elastic properties of the ascending aorta in patients with rheumatoid arthritis 34
Anti-MJ/NXP-2 autoantibody specificity in a cohort of adult Italian patients with polymyositis/dermatomyositis 34
Additional organs involved in antiphospholipid syndrome : eye, ear-nose-throat, lung, gastroenteric system, endocrine glands 33
The Th17 axis in psoriatic disease : pathogenetic and therapeutic implications 33
Short-Term Adverse Events and Antibody Response to the BNT162b2 SARS-CoV-2 Vaccine in 4156 Health Care Professionals 32
Anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus patients with articular involvement: a predictive marker for erosive disease? 32
Dose-Dependent Impairment of the Immune Response to the Moderna-1273 mRNA Vaccine by Mycophenolate Mofetil in Patients with Rheumatic and Autoimmune Liver Diseases 32
Anti-RNA polymerase III antibodies as a risk marker for early gastric antral vascular ectasia (GAVE) in systemic sclerosis 31
Autoantibodies as biomarkers for interstitial lung disease in idiopathic inflammatory myositis and systemic sclerosis: The case of anti-eIF2B antibodies 31
Anti-Th/To are common antinucleolar autoantibodies in Italian patients with scleroderma 31
Anti-argonaute2 (Ago2/Su) and -Ro antibodies identified by immunoprecipitation in primary anti-phospholipid syndrome (PAPS) 30
Isotype switching and titer variation of anti-Ro/SSA antibodies over time in 100 patients with undifferentiated connective tissue disease (UCTD) 30
Clinical Significance of Antinucleolar Antibodies: Biomarkers for Autoimmune Diseases, Malignancies, and others 30
Reference standards for the detection of anti-mitochondrial and anti-rods/rings autoantibodies 30
Long-term Outcome of Children Born to Women with Autoimmune Rheumatic Diseases: A Multicentre, Nationwide Study on 299 Randomly Selected Individuals 29
AUTOANTIBODY TO RNA-PROTEIN COMPLEX DETECTED BY QUANTITATIVE PCR 29
Antigen Reactivity and Clinical Significance of Autoantibodies Directed Against the Pyruvate Dehydrogenase Antigen Complex in Patients With Connective Tissue Disease 28
[TNF-alpha inhibition in anti-Ro/SSA positive patients with rheumatoid arthritis: clinical and immunologic effects] 26
Systemic Sclerosis-Specific Antibodies: Novel and Classical Biomarkers 26
Environmental triggers for connective tissue disease: the case of COVID-19 associated with dermatomyositis-specific autoantibodies 26
Calcinosis in poly-dermatomyositis: clinical and laboratory predictors and treatment options 25
The interplay of epigenetics and epidemiology in autoimmune diseases: time for geoepigenetics 25
MicroRNAs and autoimmunity 25
Neuropsychiatric aid in children born to patients with rheumatic diseases 25
Gender and ethnicity differences in the prevalence of scleroderma-related autoantibodies 24
Complement cascade in systemic lupus erythematosus: analyses of the three activation pathways 24
Psoriatic arthritis induced by anti-PD1 and treated with apremilast: a case report and review of the literature 23
Autoantibodies to survival of motor neuron complex in patients with polymyositis: immunoprecipitation of D, E, F, and G proteins without other components of small nuclear ribonucleoproteins 23
Cardiological features in idiopathic inflammatory myopathies 23
The geoepidemiology of autoimmune liver disease 23
Frequent coexistence of anti-topoisomerase I and anti-U1RNP autoantibodies in African American patients associated with mild skin involvement: a retrospective clinical study 22
Evaluation of mortality, disease activity, treatment, clinical and immunological features of adult and late onset systemic Lupus erythematosus 22
Differential reactivity to IMPDH2 by anti-rods/rings autoantibodies and unresponsiveness to pegylated interferon-alpha/ribavirin therapy in US and Italian HCV patients 22
MicroRNA-146a in autoimmunity and innate immune responses 22
Clinical Trials Supporting the Role of the IL-17/IL-23 Axis in Axial Spondyloarthritis 22
Atypical clinical presentation of a subset of patients with anti-RNA polymerase III--non-scleroderma cases associated with dominant RNA polymerase I reactivity and nucleolar staining 21
Malignancies in Italian patients with systemic sclerosis positive for anti-RNA polymerase III antibodies 21
Autoantibodies to transcription intermediary factor TIF1β associated with dermatomyositis 21
Medical cannabis and cannabinoids in rheumatology: where are we now? 20
Lupus T cells switched on by DNA hypomethylation via microRNA? 20
An Italian Multicenter Study on Anti-NXP2 Antibodies: Clinical and Serological Associations 20
Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy 20
Aortic stiffness and left ventricular hypertrophy in rheumatoid arthritis: comment on the article by Rudominer et al 20
ANTI-RNA POLYMERASE III ANTIBODIES AS A RISK MARKER FOR EARLY DEVELOPMENT OF GASTRIC ANTRAL VASCULAR ECTASIA IN SYSTEMIC SCLEROSIS 19
Treatment with etanercept in six patients with chronic hepatitis C infection and systemic autoimmune diseases 19
Treatment of lupus skin involvement with quinacrine and hydroxychloroquine 19
Evaluation of a novel particle-based assay for detection of autoantibodies in idiopathic inflammatory myopathies 19
Impact of chronic exposure to 5-alpha reductase inhibitors on the risk of hospitalization for COVID-19: a case-control study in male population from two COVID-19 regional centers of Lombardy, Italy 19
A new immunoprecipitation-real time quantitative PCR assay for anti-Th/To and anti-U3RNP antibody detection in systemic sclerosis 18
Elevated signal transducers and activators of transcription 1 correlates with increased C-C motif chemokine ligand 2 and C-X-C motif chemokine 10 levels in peripheral blood of patients with systemic lupus erythematosus 18
International cohort study of 73 anti-Ku-positive patients: association of p70/p80 anti-Ku antibodies with joint/bone features and differentiation of disease populations by using principal-components analysis 17
Unusual association between pure red cell aplasia and primary Sjögren's syndrome: a case report 17
Coexistence of anti-RNA polymerase III and anti-U1RNP antibodies in patients with systemic lupus erythematosus: two cases without features of scleroderma 16
Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real???Life Setting 15
LUPUS ERITEMATOSO SISTEMICO AD ESORDIO TARDIVO: CARATTERISTICHE CLINICHE ED IMMUNOLOGICHE 15
ANTICORPI ANTI-PEPTIDE CITRULLINATO CICLICO (ANTI-CCP): QUALE UTILITA' NELLA DIAGNOSI DIFFERENZIALE TRA ARTRITE REUMATOIDE E CONNETTIVITI? 15
Rpp25 is a major target of autoantibodies to the Th/To complex as measured by a novel chemiluminescent assay 14
Sex and autoimmune disease: Four mechanisms pointing at women 14
Racial differences in systemic sclerosis disease presentation: a European Scleroderma Trials and Research group study 14
mRNA COVID-19 vaccine booster fosters B- and T-cell responses in immunocompromised patients 14
ANTICORPI ANTI-RNA POLIMERASI III: UN MARKER DI ESORDIO PRECOCE DI SCLEROSI SISTEMICA 13
Rheumatoid factor and anti-citrullinated peptide antibodies in the general population: hepatitis B and C virus association and 15-year-risk of rheumatoid arthritis 13
Serum IFI16 and anti-IFI16 antibodies in psoriatic arthritis 13
MicroRNAs in Axial Spondylarthritis: an Overview of the Recent Progresses in the Field with a Focus on Ankylosing Spondylitis and Psoriatic Arthritis 13
Common pathways of autoimmune inflammatory myopathies and genetic neuromuscular disorders 12
Prevalence and clinical associations of anti-Ku antibodies in systemic autoimmune diseases 12
Testing for myositis specific autoantibodies: Comparison between line blot and immunoprecipitation assays in 57 myositis sera 11
Lymphocyte modulation by tofacitinib in patients with rheumatoid arthritis 11
LEFT VENTRICULAR FUNCTION IN RHEUMATOID ARTHRITIS DURING ANTI-TNF ALPHA TREATMENT: PROSPECTIVE STUDY 11
Unmet needs and perspectives in rheumatoid arthritis-associated interstitial lung disease: A critical review 11
Totale 3.574
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.957
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.957
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021250 0 4 9 0 0 69 29 15 58 25 2 39
2021/2022139 8 1 1 32 2 1 4 17 12 14 28 19
2022/20231.467 75 102 120 189 126 141 5 179 251 131 128 20
2023/20241.155 126 76 257 91 48 178 75 31 20 60 63 130
2024/2025821 38 37 636 57 53 0 0 0 0 0 0 0
Totale 3.832